Symposium Links
Stay Tuned...
for ‘Making the Case for Multi-Purpose Prevention Technologies for Sexual and Reproductive Health’, a document created by the Initiative to Advance Prevention Technologies for Sexual and Reproductive Health (IAPT).
Derven Patrick (UNFPA)
Caitlin Kennedy and Roxanne Hanna-Ware
Adrienne Schroeder (UCSF)
Advancing Prevention Technologies for Sexual and Reproductive Health (SRH 2009)
Jean-Paul Ngueya, Bidia Deperthes, Patrick Dervan, Papa Salif Sow
Poster Presentations & Abstracts
Poster abstracts are available in PDF format only. Click on a hyperlinked abstract number to view or download individual presentations. Authors retain copyright over these presentations and requests for use should be directed accordingly.
Posters were presented in four categories: devices, integration, microbicides, and vaccines. Download a list of all poster presentations here.
Devices
Anthony Ham and Meredith Clark
Formulation of IQP-0528 into intravaginal rings as a topical microbicide for the prevention of HIV. Abstract D-1.
Ham A, Watson K, Yang L, Buckheit C, Mahalingam A, Johnson T, Kiser P, Buckheit R
Integration
Promoting behavioral maintenance strategies for youth in Maidan community. Abstract I-1.
Agochukwu C
HIV and STI education: an integral component of HIV biomedical prevention efforts. Abstract I-2.
Amuamuziam A, Akanni O, Ukpong M
Health benefits to a community participating in HIV/AIDS research programme, Lagos, Nigeria. Abstract I-3.
Audu K
Women's perspectives on the roll-out of male circumcision as an HIV prevention tool. Abstract I-4.
Feuer C
Reproductive intentions and outcomes among women on antiretroviral therapy in rural Uganda: a prospective cohort study. Abstract I-5.
Homsy J
WORLD’s POWERR Project. Abstract I-6.
Hughes B
Linking sexual and reproductive health and HIV interventions: a systematic review and meta-analysis. Abstract I-7.
Kennedy C
Advocacy in advancing prevention technologies for sexual and reproductive health. Abstract I-8.
Mulatya J
Targeting radio for HIV/AIDS/STDs prevention in Nigeria: challenges and opportunities (Kunamatata). Abstract I-9.
Ndubuisi O, Uzoho C
Promoting sexual and reproduction health by the regulation of behavioral attitudes and the diversification of information. Abstract I-10.
Ngueya J
Involving opinion leaders in the search for an appropriate vocabulary for HIV vaccine trials in Nigeria. Abstract I-11.
Onigbogi O
Introducting the Female Condom-Experiances from the English-Ductch Speaking Carribean (abstract not available)
Patrick D
Microbicides
Rectal microbicides is not known in rural Nigeria...right groups proffer solution! Abstract M-1.
Ekerete-Udofia C
Improving solubility of dapivirine by using nanotechnology. Abstract M-2.
Garg S
Anal sex regarded as a taboo in southwest Nigeria makes rectal microbicides unacceptable: human rights activist comes with a solution! Abstract M-3.
Goodluck O
Evaluating the potential for a male microbicide among fisherman along Lake Victoria in Kisumu district, Kenya. Abstract M-4.
Kwena Z, Sang N, Omondi E, Ochieng J, Bukusi E
Transport theory for HIV migration through in vivo distributions of microbicide epithelial coating layers. Abstract M-5.
Lai B, Henderson M, Peters J, Walmer D, Katz D
SPL7013, a dendrimer-based microbicide, demonstrates a high genetic barrier for the development of drug-resistant HIV-1 in vitro. Abstract M-6.
Lewis G, Paull J
Vaginal lactobacillus bioengineered for mucosal delivery of the anti-HIV molecules. Abstract M-7.
Liu X, Liu Y, Yu R, Lagenaur L, Cheng A, Jia L, Xia Q, Hamer D, Sanders B, Lee P, Xu Q
Linking biophysical functions to user perceptions and acceptability in preclinical product development. Abstract M-8.
Morrow K, Fava J, Rosen R, Kiser P, Katz D
Epithelial coating flow biophysics for microbicide delivery. Abstract M-9.
Park S, Szeri A, Gorham A, Katz D
Clinical trial recruitment in the 21st century: integrating internet strategies for domestic trials. Abstract M-10.
Schroeder A
Novel and unique dual strategy for HIV prevention. Abstract M-11.
Shihata A
Progress in the development of a microbicide vaginal tablet. Abstract M-12.
Stone A, Neurath R
Cost-effectiveness of a hypothetical microbicide intervention. Abstract M-13.
Verguet S, Walsh J
Reframing behavioral acceptability of microbicide gel vehicles in conjunction with biophysical constraints. Abstract M-14.
Verguet S, Young Holt B, Szeri A
Preventing sexual transmission: MAPP66, a multi-purpose vaginal microbicide. Abstract M-15.
Zeitlin L, Bohorova N, Hiatt A, Pauly M, Kim D, Ho A, Velasco J, Whaley K
Vaccines
Predictors of physicians' intention to recommend HPV vaccination in Mysore, India. Abstract V-1.
Krupp K, Madhivanan P
A qualitative study on the acceptability of HPV vaccination in Mysore, India. Abstract V-2.
Madhivanan P, Krupp K
HPV infections and cervical lesions in HIV-1 and HIV-2 infected Senegalese women. Abstract V-3.
Sow PS
The vaccine and microbicide alliance. Abstract V-4.
Arntzen C, Herbst-Kralovetz M, Mason H, Tacket C, Khanna N, Zeitlin L, Whaley K